Merck Pill Intended to Treat Covid-19 Succeeds in Key Study - WSJ

Merck Pill Intended to Treat Covid-19 Succeeds in Key Study - WSJ: The drug from Merck and Ridgeback Biotherapeutics cut the risk of hospitalization or death among subjects by 50% in an early look at the study’s progress.